スポンサーリンク
Department Of Internal Medicine Fukuoka University | 論文
- Prevalence of Bartonella henselae in granulomatous lymphadenitis : A useful tool for the diagnosis of cat-scratch disease by polymerase chain reaction
- Clinical and Genetic Characterisitics of Japanese Burkitt Lymphomas with or without Leukemic Presentation
- Effect of Low Intensity Aerobic Training on Skeletal Muscle Capillary and Blood Lipoprotein Profiles
- Elevated Serum-Soluble Fas Ligand in Histiocytic Necrotizing Lymphadenitis
- Prognostic clinicopathologic factors, including immunologic expression in diffuse large B-cell lymphomas
- Clinicopathological findings of virus-associated hemophagocytic syndrome in bone marrow : Association with Epstein-Barr virus and apoptosis
- Expressions of cyclin E, A, and B1 in Hodgkin and Reed-Sternberg cells : Not suppressed by cyclin-dependent kinase inhibitor p21 expression
- Basic Fibroblast Growth Factor and Fibrosis in Hodgkin's Disease
- CD95 (Fas) ligand expression of Epstein-Barr virus (EBV)-infected lymphocytes : A possible mechanism of immune evasion in chronic active EBV infection
- Clinicopathological study of severe chronic active Epstein-Barr virus infection that developed in association with lymphoproliferative disorder and/or hemophagocytic syndrome
- A patient with acute myeloid leukemia who developed fatal pneumonia caused by carbapenem-resistant Bacillus cereus
- Fluid Retention During Thalidomide Therapy for Refractory Multiple Myelomas
- Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era
- Interferon-α and zidovudine for relapsed/refractory adult T cell leukemia/lymphoma : case reports of Japanese patients
- A phase I study of bortezomib in combination with doxorubicin and intermediate-dose dexamethasone (iPAD therapy) for relapsed or refractory multiple myeloma
- Advances in therapies for acute promyelocytic leukemia
- Successful treatment by donor lymphocyte infusion of adult T-cell leukemia/lymphoma relapse following allogeneic hematopoietic stem cell transplantation
- Initial low-dose valganciclovir as a preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients